The application of artificial intelligence to understand the pathophysiological basis of psychogenic nonepileptic seizures.

Journal: Epilepsy & behavior : E&B
Published Date:

Abstract

Psychogenic nonepileptic seizures (PNES) are episodes of paroxysmal impairment associated with a range of motor, sensory, and mental manifestations, which perfectly mimic epileptic seizures. Several patterns of neural abnormalities have been described without identifying a definite neurobiological substrate. In this multicenter cross-sectional study, we applied a multivariate classification algorithm on morphological brain imaging metrics to extract reliable biomarkers useful to distinguish patients from controls at an individual level. Twenty-three patients with PNES and 21 demographically matched healthy controls (HC) underwent an extensive neuropsychiatric/neuropsychological and neuroimaging assessment. One hundred and fifty morphological brain metrics were used for training a random forest (RF) machine-learning (ML) algorithm. A typical complex psychopathological construct was observed in PNES. Similarly, univariate neuroimaging analysis revealed widespread neuroanatomical changes affecting patients with PNES. Machine-learning approach, after feature selection, was able to perform an individual classification of PNES from controls with a mean accuracy of 74.5%, revealing that brain regions influencing classification accuracy were mainly localized within the limbic (posterior cingulate and insula) and motor inhibition systems (the right inferior frontal cortex (IFC)). This study provides Class II evidence that the considerable clinical and neurobiological heterogeneity observed in individuals with PNES might be overcome by ML algorithms trained on surface-based magnetic resonance imaging (MRI) data.

Authors

  • Roberta Vasta
    Neuroscience Research Center, Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Italy.
  • Antonio Cerasa
    Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), 88100 Catanzaro, Italy; S. Anna Institute and Research in Advanced Neurorehabilitation (RAN), 88900 Crotone, Italy. Electronic address: antonio.cerasa76@gmail.com.
  • Alessia Sarica
    Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), 88100 Catanzaro, Italy.
  • Emanuele Bartolini
    Neurology Unit and Laboratories, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
  • Iolanda Martino
    Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), 88100 Catanzaro, Italy.
  • Francesco Mari
    Neurology Unit and Laboratories, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
  • Tiziana Metitieri
    Neurology Unit and Laboratories, A. Meyer Children's Hospital, University of Florence, Florence, Italy.
  • Aldo Quattrone
    Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), 88100 Catanzaro, Italy; Institute of Neurology, Department of Medicine, "Magna Graecia" University, 88100 Catanzaro, Italy.
  • Antonio Gambardella
    § Magna Græcia University, Catanzaro, Italy.
  • Renzo Guerrini
    Neurology Unit and Laboratories, A. Meyer Children's Hospital, University of Florence, Florence, Italy; Imago7, IRCCS Stella Maris Foundation, Pisa, Italy. Electronic address: renzo.guerrini@meyer.it.
  • Angelo Labate
    § Magna Græcia University, Catanzaro, Italy.